
News|Articles|August 1, 2006
Pipeline Preview (August 2006)
Hepatitis B immune globulin (human) (Nabi-HB, Nabi Bio-pharmaceuticals) for the treatment of hepatitis B infection
Advertisement
Recommendations for approval
Approvable designations
Fast-track designations
Orphan drug designations
Non-approvable designations
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Eylea HD Provides Vision Gains and Longer Dosing Intervals in Real-World Analysis | AAO 2025
2
Real-World Data Shows Vision Decline as Copay Programs Run Dry | AAO 2025
3
El Niño and La Niña Affect Eye Health Too, Not Just Weather | AAO 2025
4
In AI vs. Humans, AI Can ‘Surpass’ and By Far | AAO 2025
5